<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>XBI &mdash; Nicox: regulatory approval | Trader Notes</title>
    <style>
        * { margin: 0; padding: 0; box-sizing: border-box; }
        body { font-family: 'Lato', -apple-system, sans-serif; background: #FFF1E5; color: #1a1a2e; line-height: 1.6; }
        .container { max-width: 760px; margin: 0 auto; padding: 1.5rem; }
        a { color: #0d7680; }
    </style>
    <link href="https://fonts.googleapis.com/css2?family=Playfair+Display:wght@700&family=Lato:wght@300;400;700&display=swap" rel="stylesheet">
</head>
<body>
<div class="container">
    <div style="margin-bottom:1rem">
        <a href="../" style="font-size:0.8rem;color:#6b7280;text-decoration:none">&larr; Back to Trading Sheet</a>
    </div>

    <div style="display:flex;align-items:center;gap:12px;margin-bottom:0.5rem;flex-wrap:wrap">
        <span style="font-family:'Playfair Display',serif;font-size:1.8rem;font-weight:700">XBI</span>
        <span style="font-size:0.8rem;padding:4px 12px;border-radius:12px;color:#6b7280;background:#f1f5f9;font-weight:700">WATCHING</span>
        <span style="font-size:0.85rem;color:#6b7280">LONG 55% &middot; Band B</span>
    </div>
    <div style="font-size:1rem;color:#4b5563;margin-bottom:0.5rem">Nicox: regulatory approval</div>

    <div style="display:flex;gap:1.5rem;flex-wrap:wrap;margin:1rem 0"><div><div style="font-size:0.7rem;color:#6b7280;text-transform:uppercase">DD Price</div><div style="font-weight:700;font-size:1.1rem">$122.86</div></div><div><div style="font-size:0.7rem;color:#6b7280;text-transform:uppercase">Current</div><div style="font-weight:700;font-size:1.1rem">$122.86</div></div><div><div style="font-size:0.7rem;color:#7c3aed;text-transform:uppercase">Report P&amp;L</div><div style="font-weight:700;font-size:1.1rem;color:#7c3aed">+0.0%</div></div></div>
    <div style="margin:0.5rem 0"><span style="display:inline-block;padding:3px 10px;border-radius:12px;font-size:0.75rem;font-weight:700;color:#166534;background:#dcfce7">INTACT</span> <span style="display:inline-block;padding:3px 10px;border-radius:12px;font-size:0.75rem;font-weight:700;color:#166534;background:#dcfce7">&#128263; quiet (0)</span></div>
    <div style="margin:1rem 0">
                <div style="font-size:0.75rem;color:#6b7280;font-weight:700;text-transform:uppercase;letter-spacing:0.05em;margin-bottom:4px">Conviction</div>
                <div style="display:flex;align-items:center;gap:10px">
                    <div style="flex:1;max-width:200px;height:8px;background:#e5e7eb;border-radius:4px;overflow:hidden">
                        <div style="width:60%;height:100%;background:#f59e0b;border-radius:4px"></div>
                    </div>
                    <span style="color:#f59e0b;font-weight:700;font-size:1.1rem">6/10</span>
                </div>
            </div>
    <div style="background:#f9fafb;border-radius:6px;padding:0.8rem 1rem;margin:0.8rem 0;font-size:0.85rem;color:#374151;border-left:3px solid #6b7280"><strong>Status:</strong> DD approved — watching for signal confirmation</div>
    <div style="margin:1rem 0;padding:1rem;background:#fefce8;border-radius:6px;border-left:3px solid #eab308"><div style="font-size:0.75rem;color:#92400e;font-weight:700;text-transform:uppercase;letter-spacing:0.05em;margin-bottom:6px">Original Report Thesis</div><div style="font-size:0.85rem;color:#374151;margin-bottom:6px"><strong>Mechanism:</strong> This is a clean, issuer-specific regulatory milestone: Nicox reports positive written feedback from a pre-NDA meeting with the US FDA for NCX 470 and reiterates that NDA submission is on track for summer 2026, with partner economics referenced. The mechanism is straightforward and supports a LONG call on the proxy instrument: pre-NDA alignment reduces execution uncertainty around the submission pa</div><div style="font-size:0.85rem;color:#374151;margin-bottom:6px"><strong>Tripwire:</strong> The macro tape is Mixed 55 with crosswind 60, so the market may not reward single-stock milestones cleanly on day one, especially when the evidence base is issuer-led. Freshness is 85/100 and the posture is IGNITE, so attention can ramp quickly once the milestone circulates. The tripwires are (1) an</div><div style="font-size:0.85rem;color:#374151;margin-bottom:6px"><strong>Evidence:</strong> The primary hydrated artefact is the press release hosted on globenewswire.com. 7A flags this as issuer-sourced but specific (named regulator, asset, partner, and date window), with validation status unconfirmed due to the unavailable 7.1 overlay rather than a contradictory check.</div></div>
    <div style="background:#f0fdf4;border-radius:6px;padding:0.8rem 1rem;margin:0.8rem 0;font-size:0.85rem;border-left:3px solid #22c55e"><strong>&#128269; Watching For:</strong> I will look for updates from Nicox about the NDA submission timeline, partner confirmation from Kowa, and early signs of news coverage expanding to additional outlets, which could add momentum to the narrative.</div>
    <div style="background:#fff7ed;border-radius:6px;padding:0.8rem 1rem;margin:0.8rem 0;font-size:0.85rem;border-left:3px solid #f97316"><strong>&#9888; Concerns:</strong> The primary worry is that the lack of interest from news sources may diminish the opportunity. If this situation continues without any signs of movement or updates, it may affect the potential for entering a trade.</div>
    <div style="margin:1.5rem 0"><div style="font-size:0.8rem;color:#6b7280;font-weight:700;text-transform:uppercase;letter-spacing:0.05em;margin-bottom:0.8rem;padding-bottom:4px;border-bottom:1px solid #e5e7eb">Private Narrative Log</div><div style="margin-bottom:1rem;padding:0.8rem 1rem;background:white;border-radius:6px;border-left:3px solid #d1d5db;box-shadow:0 1px 2px rgba(0,0,0,0.04)"><div style="font-size:0.85rem;color:#374151;line-height:1.6">As I reflect on my previous entries, the situation is still very much in a holding pattern. While the regulatory mechanism is clear and the feedback from the FDA is positive, the continuing silence in terms of media interest and market reaction has me cautious. My conviction is stable at 6/10, which is revealing both strength in the regulatory narrative as well as concern over lack of propagation. If I start to see more evidence of increasing awareness, particularly from reputable media or partnerships, that would significantly bolster my confidence to enter a position. For the moment, I will </div><div style="font-size:0.7rem;color:#9ca3af;margin-top:4px">Cycle 4 &middot; 2026-02-16T16:36</div></div><div style="margin-bottom:1rem;padding:0.8rem 1rem;background:white;border-radius:6px;border-left:3px solid #d1d5db;box-shadow:0 1px 2px rgba(0,0,0,0.04)"><div style="font-size:0.85rem;color:#374151;line-height:1.6">While the thesis continues to appear sound with a clear regulatory mechanism supported by the FDA feedback, the quiet status is a cause for caution. My conviction sits at a moderate level (6/10), reflecting both the strength of the regulatory milestone and the current market's indifference. With no movement in the price or media coverage, I find myself in a holding pattern, awaiting signs of increased activity. As I continue to watch for partner confirmations and any updates from Nicox, I feel it’s prudent to remain patient. If momentum builds in terms of news coverage or direct confirmation f</div><div style="font-size:0.7rem;color:#9ca3af;margin-top:4px">Cycle 3 &middot; 2026-02-16T15:35</div></div></div>
    <div style="margin:1.5rem 0"><div style="font-size:0.8rem;color:#6b7280;font-weight:700;text-transform:uppercase;letter-spacing:0.05em;margin-bottom:0.8rem;padding-bottom:4px;border-bottom:1px solid #e5e7eb">Due Diligence Log</div><div style="margin-bottom:0.8rem;padding:0.6rem 1rem;background:#f9fafb;border-radius:6px;border-left:3px solid #16a34a"><div style="display:flex;justify-content:space-between;align-items:center;margin-bottom:4px"><span style="font-weight:700;color:#16a34a">TRADE</span><span style="font-size:0.7rem;color:#9ca3af">pre_trade &middot; </span></div><div style="font-size:0.82rem;color:#374151">Fresh signal (1h), price stable (0.0% move), confidence 55%</div><div style="font-size:0.72rem;color:#6b7280;margin-top:3px">Price: $122.86 | Move: 0.0% | Staleness: 1h</div></div></div>
    <div style="margin:1.5rem 0"><div style="font-size:0.8rem;color:#6b7280;font-weight:700;text-transform:uppercase;letter-spacing:0.05em;margin-bottom:0.8rem;padding-bottom:4px;border-bottom:1px solid #e5e7eb">Price History</div><div style="display:flex;flex-wrap:wrap;gap:6px"><span style="font-size:0.7rem;color:#7c3aed;padding:2px 6px;background:#f9fafb;border-radius:4px">13:57 $122.86 +0.0%</span><span style="font-size:0.7rem;color:#7c3aed;padding:2px 6px;background:#f9fafb;border-radius:4px">15:23 $122.86 +0.0%</span><span style="font-size:0.7rem;color:#7c3aed;padding:2px 6px;background:#f9fafb;border-radius:4px">16:33 $122.86 +0.0%</span><span style="font-size:0.7rem;color:#7c3aed;padding:2px 6px;background:#f9fafb;border-radius:4px">22:45 $122.86 +0.0%</span></div></div>

    <div style="margin-top:2rem;padding-top:1rem;border-top:1px solid #e5e7eb;font-size:0.72rem;color:#9ca3af;text-align:center">
        Position #4 &middot; Updated 2026-02-16 23:23 UTC &middot; <a href="../" style="color:#9ca3af">Back to Trading Sheet</a>
    </div>
</div>
</body>
</html>